IN THE NEWS

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market. By Jenny Rood | October 1, 2016. Around Christmas 2010, University of Minnesota researcher Mark Suckow received terrible news:...

Purchase price of US$6.72 per share, or approximately US$85 million in aggregate Acquisition to strengthen Zoetis’ pipeline in companion animal therapeutics for chronic pain, a global area estimated at US$400 million annually 1 PARSIPPANY, N.J. & TULLAMORE,...

By Mary Guiden, Communications Coordinator, CSU.   Through its clinical trials for animal patients, Colorado State University helped prove the usefulness of the first drug approved by the FDA for treatment of canine lymphoma, a breakthrough in veterinary oncology...

Provides Hope for Humans When Krista DeZerega-Thomson got the dreaded news that Rohan, the family’s beloved Labrador retriever, had cancer, she was devastated. He had metastatic melanoma—an aggressive form that affects dogs and humans—and was given only two months to...

Fred, a 6-year-old male shepherd cross, was diagnosed by his referring veterinarian with cancer in his left forelimb in April 2016. Due to preexisting orthopedic issues, he was not a candidate for the traditional amputation and chemotherapy treatment. Faced with only...

Researchers at Baylor College of Medicine have been awarded a $500,000 grant from the National Institutes of Health that will increase our understanding about the interactions between cancer and the immune system in dogs with naturally occurring tumors. The grant...

By Arlene Weintraub, FiercePharma, September 30, 2016. Animal health has long been considered a safe investment, because even during tough economic times, most pet owners don’t scrimp on spending when it comes to keeping their dogs and cats healthy. And the food side...

By Helaine Olen, Slate, September 27, 2016. Pets certainly know how to sink their teeth into a household budget. In 2015, my poodle’s long-lasting stomach virus set my family back by almost four figures. Later in the year we got an even heftier bill for a canine root...

NOTE: Poïesis is thrilled to announce that Laurent Fischer, MD, CEO of Tobira Therapeutics and an Advisor to the company has just presided over the acquisition of Tobira by Allergan plc for $1.7 Billion!   By Tess Stynes, The Wall Street Journal, September 20, 2016....

By Sarah Evers Conrad, The Horse, September 9, 2016. Studying diseases across species can benefit horses as well as people -- Similarities between veterinary medicine and human medicine abound, particularly when it comes to horses. Horses, after all, suffer from many...